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The nucleocapsid (N) protein of mouse hepatitis virus (MHV) and the cellular heterogeneous nuclear ribonucleoprotein A1
(hnRNP-A1) are RNA-binding proteins, binding to the leader RNA and the intergenic sequence of MHV negative-strand
template RNAs, respectively. Previous studies have suggested a role for both N and hnRNP-A1 proteins in MHV RNA
synthesis. However, it is not known whether the two proteins can interact with each other. Here we employed a series of
methods to determine their interactions both in vitro and in vivo. Both N and hnRNP-A1 genes were cloned and expressed
in Escherichia coli as glutathione S-transferase (GST) fusion proteins, and their interactions were determined with a
GST-binding assay. Results showed that N protein directly and specifically interacted with hnRNP-A1 in vitro. To dissect the
protein-binding domain on the N protein, 15 deletion constructs were made by PCR and expressed as GST fusion proteins.
Two hnRNP-A1-binding sites were identified on N protein: site A is located at amino acids 1 to 292 and site B at amino acids
392 to 455. In addition, we found that N protein interacted with itself and that the self-interacting domain coincided with site
A but not with site B. Using a fluorescence double-staining technique, we showed that N protein colocalized with hnRNP-A1
in the cytoplasm, particularly in the perinuclear region, of MHV-infected cells, where viral RNA replication/transcription
occurs. The N protein and hnRNP-A1 were coimmunoprecipitated from the lysates of MHV-infected cells either by an N- or
by an hnRNP-A1-specific monoclonal antibody, indicating a physical interaction between N and hnRNP-A1 proteins. Further-
more, using the yeast two-hybrid system, we showed that N protein interacted with hnRNP-A1 in vivo. These results thus
establish that MHV N protein interacts with hnRNP-A1 both in vitro and in vivo. © 1999 Academic Press
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Mouse hepatitis virus (MHV), a prototype of murine
oronavirus, is a member of the Coronaviridae family.
HV contains a single-strand, positive-sense RNA ge-
ome of 31 kb in length (Pachuk et al., 1989; Lee et al.,
991; Lai and Cavanagh, 1997). Upon infection, the viral
enomic RNA serves as a template for synthesis of a
egative-strand, genome-length RNA, which in turn
erves as a template for synthesis of six to seven sub-
enomic mRNAs (Lai and Cavanagh, 1997, and refer-
nces therein). Each subgenomic mRNA contains a
eader RNA of 72–77 nucleotides in length at the 59-end,
hich is identical to the genomic RNA leader (Lai et al.,
983, 1984). Depending on virus strains, there are two to
our UCUAA repeats at the 39-end of the leader, with the
ast repeat being UCUAAAC (Makino and Lai, 1989). An
dentical consensus UCUAAAC or similar sequence is
resent between each gene, termed intergenic (IG) se-
uence (Budzilowicz et al., 1985; Shieh et al., 1989),
hich serves as a joining point between the leader and
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ock, AR 72205. Fax: (501) 686-5359. E-mail: zhangxuming@txchange.uams.edu.
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96he body of a subgenomic mRNA. These subgenomic
RNAs are co-nested at the 39-end. Double-stranded
eplicative-form RNAs and subgenomic negative-
tranded RNAs complementary to each subgenomic
RNA are also found in infected cells (Sethna et al.,
989; Sawicki and Sawicki, 1990). It has been suggested
hat the subgenomic minus-stranded RNAs might be first
ynthesized from the full-length genomic RNA template
uring initial transcription and that they subsequently
erve as templates for synthesis of subgenomic mRNAs
Sawicki and Sawicki, 1995).
The precise mechanism(s) of MHV RNA transcription,
owever, remains elusive. Based on the structural fea-
ures of the leader–body joining site of each subgenomic
RNA and the sequence complementarity between the
9-end of the leader (59-UCUAAAC-39) and the consensus
G sequence of the negative-strand template (39-
GAUUUG-59), the leader-primed transcription model
as proposed to explain how the leader RNA joins to the
G sequence to initiate subgenomic mRNA transcription
Lai et al., 1983; Spaan et al., 1983; Baric et al., 1985). A
umber of subsequent experimental findings are com-
atible with this model (Lai and Cavanagh, 1997, and
eferences therein). Using a mutant MHV, JHM2c, how-
ver, we previously found that a subgenomic mRNA
pecies (mRNA2-1) can be initiated at a site other thanhe authentic UAAUAAAC sequence, where there is no
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97INTERACTION BETWEEN MHV N AND hnRNP-A1equence complementarity between the leader and the
emplate IG region (Zhang and Lai, 1994). This kind of
RNA initiation was also observed in a recombinant
HV A59 expressing a green fluorescence protein (Fish-
r et al., 1997). To explain how the leader joins to the IG
egion without sequence complementarity between
hem, we proposed that both the leader RNA and the IG
equence of the template may first interact with some
ellular and/or viral proteins through protein–RNA inter-
ctions and that these two RNA elements are then
rought together through protein–protein interactions to
orm a transcription initiation complex (Zhang et al.,
994b; Zhang and Lai, 1994). Subsequently, using UV
ross-linking and gel retardation assays, we and others
ave identified some cellular proteins that specifically
nteract with the cis-acting sequences of MHV RNA (Fu-
uya and Lai, 1993; Yu and Leibowitz, 1995; Zhang and
ai, 1995; Li et al., 1997, 1999).
One of the cellular RNA-binding proteins has been
dentified as heterogeneous nuclear ribonucleoprotein
1 (hnRNP-A1) (Li et al., 1997). hnRNP-A1 binds to the
egative-strand leader and IG sequences, particularly
he consensus (39-AGAUUUG-59) sequence of MHV RNA.
ite-directed mutagenesis analysis of the IG consensus
equence further suggests a role of hnRNP-A1 in MHV
ranscriptional regulation (Zhang and Lai, 1995). Al-
hough hnRNP-A1 is a nuclear protein, it relocalizes from
he nucleus to the cytoplasm during MHV infection; this
ntracellular relocalization appears to be specific for
nRNP-A1 because another nuclear protein, Sam68,
hich has been shown to be relocalized to the cyto-
lasm during poliovirus infection (McBride et al., 1996),
emains in the nucleus of MHV-infected cells (Li et al.,
997). These findings suggest that there is a physical
nd possibly functional link between hnRNP-A1 and
HV RNA replication and transcription apparatus (Li et
l., 1997; Lai, 1998). Furthermore, direct evidence for a
unctional role for hnRNP-A1 in MHV RNA synthesis has
een recently demonstrated in MHV-infected cells
Zhang et al., manuscript in preparation). On the other
and, the nucleocapsid (N) protein of MHV has been
hown to bind to the UCUAAAC sequence of the leader
NA (Baric et al., 1988; Stohlman et al., 1988). It has thus
een suggested that N protein is involved in MHV RNA
ranscription (Baric et al., 1988; Stohlman et al., 1988).
he role of N protein in MHV RNA replication has also
een demonstrated in an in vitro replication system
Compton et al., 1987). These findings suggest that both
ellular hnRNP-A1 protein and viral N protein are com-
onents of the MHV replication and transcription com-
lex. However, it is not known whether they can interact
ith each other. Since hnRNP-A1 interacts with some
erine–arginine (SR)-rich proteins (Cartegni et al., 1996),
nd since N protein also contains an SR motif (Peng et
l., 1995), it is conceivable that hnRNP-A1 may interact
irectly with N protein to bring the leader RNA to the IG tequence of the template RNA for initiation of sub-
enomic mRNA transcription.
In this study, we thus explored this possibility by di-
ectly testing whether hnRNP-A1 directly interacts with
HV N protein in vitro and in vivo. We have expressed
oth hnRNP-A1 and N genes as glutathione S-trans-
erase (GST)–fusion proteins and determined their inter-
ctions by a GST-binding assay. Results showed that
nRNP-A1 directly interacted with N protein in vitro. Us-
ng a fluorescence double-staining technique, we found
hat hnRNP-A1 colocalized with N protein in the perinu-
lear region of MHV-infected cells. Immunoprecipitation
urther demonstrated a physical interaction between
nRNP-A1 and N proteins in virus-infected cells. Further-
ore, we found that hnRNP-A1 interacted with N protein
n a yeast two-hybrid system. These studies thus estab-
ish that coronavirus N protein has a protein-binding
ctivity and that it interacts with a cellular component of
he putative MHV replication and transcription complex
oth in vitro and in vivo.
RESULTS
protein interacts with hnRNP-A1 in vitro
To establish that N protein has protein-binding prop-
rties and that it can interact directly with hnRNP-A1, we
loned hnRNP-A1 and MHV N genes into pBluescript
ectors for in vitro transcription and translation and into
GEX4-1 vectors for expression of GST fusion proteins.
heir interactions were then determined by a GST-bind-
ng assay, in which one of the interacting partners is a
ST fusion protein that was immobilized on the gluta-
hione–Sepharose beads and the other was radiolabeled
ith [35S]methionine in an in vitro translation reaction.
hen the GST–N fusion protein and the in vitro trans-
ated hnRNP-A1 protein were used in the GST-binding
ssay, 35S-labeled hnRNP-A1 was detected (Fig. 1A, lane
). This interaction was specific for N protein because no
35S-labeled hnRNP-A1 was pulled down with GST alone
Fig. 1A, lane 2). The interaction was also specific for
nRNP-A1 because neither 35S-labeled GFP (green fluo-
escence protein) nor HE (hemagglutinin/esterase), an-
ther MHV structural protein, was brought down by
ST–N (Fig. 1A, lanes 3 and 4, respectively). Interest-
ngly, when the in vitro translation products of hnRNP-A1
nd HE were mixed, GST–N protein selectively brought
own hnRNP-A1 but not HE (Fig. 1A, lane 5), indicating
hat the interaction between GST–N and hnRNP-A1 was
pecific. Similarly, when the N protein was translated in
itro and hnRNP-A1 was expressed as a GST–fusion
rotein, N protein specifically bound to the GST–A1
epharose beads, but did not bind to GST (Fig. 1B).
hese results demonstrate that N protein directly inter-
cts with hnRNP-A1 in vitro.
Next, we employed co-immunoprecipitation as an al-
ernative approach to determine the interaction between
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98 WANG AND ZHANGnRNP-A1 and N proteins. GST–N fusion protein was
luted from the glutathione–Sepharose beads, mixed
ith the 35S-labeled hnRNP-A1, and immunoprecipitated
ith an N-specific monoclonal antibody (MAb). The re-
ultant complexes were isolated with protein A–agarose
eads and separated by sodium dodecyl sulfate–polyac-
ylamide gel electrophoresis (SDS–PAGE). As expected,
nRNP-A1 was detected only when the GST–N fusion
rotein was present (Fig. 2, lane 5); no hnRNP-A1 was
oprecipitated by the N-specific MAb when GST alone
as used (Fig. 2, lane 6), again demonstrating that N
rotein specifically interacted with hnRNP-A1. The re-
ults also showed that the MAb interacted specifically
ith N protein (Fig. 2, lane 4) and did not cross-react with
nRNP-A1 protein (Fig. 2, lane 2).
Because it is known that both hnRNP-A1 and N pro-
eins interact with viral RNAs and some other RNAs, it is
ossible that hnRNP-A1 might be brought down indi-
ectly through its interaction with RNAs. To investigate
his possibility, rabbit reticulocyte lysates were treated
ith micrococcal nuclease following the in vitro transla-
ion reaction. This treatment did not affect the interaction
etween hnRNP-A1 and N proteins (Fig. 3A), indicating
hat hnRNP-A1 directly interacted with N protein. The
pecificity of this interaction was further demonstrated
y a competition assay using bovine serum albumin as a
onspecific competitor (Fig. 3B). A cold specific compet-
tor (unlabeled hnRNP-A1) could not be used for this
xperiment due to the formation of oligomers with la-
eled hnRNP-A1 (data not shown). Oligomerizations
FIG. 1. Interactions between MHV N protein and hnRNP-A1 in vitro.
nd the other was labeled with [35S]methionine in an in vitro translation
n vitro translated protein were determined by a GST-binding assay (se
hown at the top left and are indicated either by names or by plus (pre
HV hemagglutinin/esterase protein; GFP, green fluorescence protein
VT-GFP; lane 4, GST–N plus IVT-HE; lane 5, GST-N plus IVT-A1 and IVT
roducts used for the binding reactions as protein controls. (B) Lane 1
nput volume of IVT products used for the binding reaction). Protein com
he gel was autoradiographed. The in vitro translated products are inmong hnRNP-A1 proteins have been reported (Dreyfuss wt al., 1993). To further establish the specificity of this
nteraction, we used a modified protocol for the compe-
ition assay using purified GST–N(III) protein as a spe-
ific competitor. GST–N(III) contains the last domain of N
rotein, which interacts with hnRNP-A1 but which does
ot interact with itself (N protein) (Fig. 6). Various
mounts (0–40 mg) of purified GST–N(III) protein were
ixed with a fixed amount (2 ml) of in vitro translated
nRNP-A1 in a protein-binding buffer (the same for GST-
inding assay) and the mixture was incubated at 4°C
vernight. Before the GST-binding assay was performed,
he GST-binding sites on GST–N-immobilized Sepharose
eads were saturated with an excess amount of GST;
ithout this treatment, GST–N(III)–hnRNP-A1 complexes
ould bind to unsaturated beads in the GST-binding
eaction through interactions between GST and glutathi-
ne on the beads and not through interactions between
nRNP-A1 and the N moiety of GST–N protein. After
aturation, the same amount of GST–N–Sepharose
eads were used in a standard GST-binding assay by
ixing it with GST–N(III)–35S-hnRNP-A1. The complexes
ere then separated by SDS–PAGE. If the interaction
etween GST–N(III) and 35S-hnRNP-A1 is specific, with
ncreasing amounts of GST–N(III), decreasing amounts
f free 35S-hnRNP-A1 would be brought down by GST–
–Sepharose beads. As expected, 35S-hnRNP-A1 was
ndeed competed by GST–N(III) protein in a concentra-
ion-dependent manner. A decrease of 35S-hnRNP-A1
as readily detectable even when only 10 mg of the
ompetitor GST–N(III), an equivalent amount to GST–N,
the two interacting proteins was expressed as a GST–fusion protein
on (IVT). Protein–protein interactions between GST–fusion protein and
rials and Methods). (A) Components of the reaction in each lane are
and minus (absence) signs at the top of the figure. A1, hnRNP-A1; HE,
1, GST–N plus IVT-A1; lane 2, GST plus IVT-A1; lane 3, GST–N plus
nes 6, 7, and 8 represent 10% of the input volume of in vitro translation
1 plus IVT-N; lane 2, GST plus IVT-N; lane 3, IVT-N alone (10% of the
were analyzed by SDS–polyacrylamide gel electrophoresis (10% gel).
on the right and molecular mass markers in kilodalton on the left.One of
reacti
e Mate
sence)
. Lane
-HE. La
, GST-A
plexes
dicatedas used in this assay (Fig. 3C, lane 3). When the
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99INTERACTION BETWEEN MHV N AND hnRNP-A1mount of GST–N(III) was increased twofold (20 mg),
nRNP-A1 was almost completely competed away (Fig.
C, lane 4). No hnRNP-A1 could bind to GST–N Sepha-
ose beads when 40 mg of the competitor GST–N(III) was
sed, which is a four times excess over GST–N (Fig. 3C,
ane 5). Taken together, these results demonstrate that N
rotein has protein-binding properties and that it inter-
cts specifically and directly with hnRNP-A1 in vitro.
haracterization of the protein-binding sites
n the N protein
Based on a sequence analysis of the N genes of five
HV strains, Parker and Masters (1990) suggested that
protein is composed of three highly conserved struc-
ural domains connected to each other by two less con-
erved spacer sequences. The amino-terminal two do-
ains (domains I and II) are basic and the carboxyl-
erminal domain is acidic. Although the RNA-binding
roperty of N protein has been mapped to be within the
iddle domain (domain II) (Masters, 1992; Nelson and
tohlman, 1993), the functions of domains I and III are
nknown. Also, the protein-binding property and binding
ites on the N protein have not been reported previously.
o dissect the protein-binding site(s) of the N protein, we
FIG. 2. Co-immunoprecipitation of in vitro translated hnRNP-A1 and
ST-N proteins by an N-specific antibody. hnRNP-A1 was labeled with
35S]methionine in an in vitro translation reaction (IVT-A1), and N protein
as expressed as a GST–fusion protein (GST–N). Immunoprecipitation
f IVT-A1 by the N-specific antibody (aN-Ab) was performed in the
resence of GST–N fusion protein (lane 5) or GST protein (lane 6). The
mmunocomplex was isolated with protein A–agarose beads and was
eparated by SDS–polyacrylamide gel (10%) electrophoresis. The gel
as autoradiographed. Lanes 1 and 3 represent 10% of the input
olume of in vitro translation products of A1 (IVT-A1) and N (IVT-N),
espectively, used for immunoprecipitation. Lane 2, IVT-A1 plus anti-N-
b, and lane 4, IVT-N plus anti-N-Ab, were controls for the specificity of
N-Ab. Bands representing hnRNP-A1 and N are indicated by arrows
n the right, molecular mass markers in kilodalton are on the left, and
ane numbers are indicated at the bottom.ade a series of deletion constructs by PCR (Fig. 4A) bnd cloned each into a pGEX4-1 vector for expression as
ST–fusion proteins. All proteins were expressed in a
ubstantial amount and the size of each fusion protein
orresponded to its expected molecular weight (Fig. 4B).
lthough some degradation was observed in a few pro-
eins, the full-length products were still predominant in
hese proteins (Fig. 4B, lanes 5, 8, 12, and 14). These
runcated GST–N fusion proteins were then used in a
ST-binding assay for determining their binding capacity
ith the in vitro translated, radiolabeled hnRNP-A1. As
hown in Fig. 5A, hnRNP-A1 bound to all GST–fusion
roteins containing domains I, IIA, and III, but did not
ind to the second half of the middle domain [GST–
(IIB), lane 9]. Further deletions of domains I and II of the
protein did not significantly affect the binding with
nRNP-A1 (Fig. 5B). We thus conclude that N protein
ontains at least two protein-binding sites: one at the
mino terminus from amino acids 1 to 292, and the other
t the carboxyl terminus from amino acids 391 to 455
Fig. 7). Because all N deletion constructs within the
mino-terminal region (domains I and IIA) bound to
nRNP-A1 with similar affinities (Fig. 5B), we could not
etermine the exact number of binding sites on this
omain (Fig. 7). The reason for this ambiguity is un-
nown. One possibility is that the amino-terminal-binding
egion contains multiple binding sites. Multiple binding
ites in a protein are common among chaperone pro-
eins with protein-interacting properties such as
nRNP-A1 (Cartegni et al., 1996).
Since N protein has protein-binding properties as
hown above, an interesting question is whether N pro-
ein can interact with itself. If so, what is the exact
ocation of the protein-binding site? To address this
uestion, we used GST–N and its deletion derivatives
mmobilized on Sepharose beads and the in vitro trans-
ated, 35S-labeled full-length N protein in a GST-binding
ssay to determine their interactions. As shown in Fig. 6,
he full-length N protein did indeed interact with itself
lane 3). Furthermore, it interacted with domains I and IIA
lanes 3 and 5) but did not bind to domains III and IIB
lanes 4 and 6). We conclude that N protein can interact
ith itself but that the binding site for N is located in
omains I and IIA and not in domains IIB and III. Thus,
he protein-binding sites on N protein for binding of N
nd hnRNP-A1 are different (Fig. 7).
protein co-localizes with hnRNP-A1 in the
ytoplasm of MHV-infected cells
Although cytoplasmic relocalization of hnRNP-A1 was
reviously observed in MHV-infected cells, it was not
lear what the correlation between cytoplasmic relocal-
zation of hnRNP-A1 and virus replication is, because
nly a single-labeling immunofluorescence assay was
erformed (Li et al., 1997). This question is important
ecause it may relate the biological role of hnRNP-A1 to
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100 WANG AND ZHANGiral replication and transcription. Also, the above in vitro
esults suggest that hnRNP-A1 protein may interact with
protein in vivo. We addressed this issue in the present
tudy by employing the double-staining immunofluores-
ence technique so that the localization of both
nRNP-A1 protein and the N protein (an indicator of virus
ene expression) can be monitored simultaneously.
ells were infected with MHV-JHM virus at a multiplicity
f infection (m.o.i.) of 1. At various times postinfection
p.i.), cells were stained simultaneously with two primary
ntibodies (a chicken antiserum specific to hnRNP-A1
nd a mouse MAb specific to N protein) and two sec-
ndary antibodies (goat anti-chicken IgG conjugated
ith rhodamine and rabbit anti-mouse IgG conjugated
ith fluorescein, respectively). Mock-infected cells were
sed as a control. Results showed that hnRNP-A1 pre-
ominantly localized in the nucleus of mock-infected
ells or of cells infected with MHV at 0 h p.i. (Fig. 8b). No
protein was detected in these cells at this time point
Fig. 8a). At 2 h p.i., cytoplasmic localization of hnRNP-A1
as occasionally observed, whereas the expression of
he N protein was still undetectable (data not shown). At
h p.i., both N and hnRNP-A1 proteins were detectable
nd they appeared to colocalize in the cytoplasm under
icroscopic examination. Confocal laser scanning mi-
roscopy further confirmed their cytoplasmic colocaliza-
ion (data not shown). At 7 h p.i., most cells were fused
nd syncytia were often observed. Cytoplasmic colocal-
zation of the two proteins was more pronounced at this
ime point but the cytoplasmic staining generally became
eaker, possibly due to diffusion of the dyes (Figs. 8d–
f). It is noted that the cytoplasmic localization of
nRNP-A1 was not found in all infected cells. In some of
he infected cells, determined by the presence of N
rotein [fluorescein isothiocyanate (FITC)-staining],
nRNP-A1 remained in the nucleus (data not shown).
onsistent with this observation is the finding that
nRNP-A1 remained in the nucleus of some cells within
syncytium (Fig. 8e). In contrast, N protein was detected
n the cytoplasm of all cells within the syncytium (Fig. 8d).
he detection of nuclear staining of hnRNP-A1 within the
yncytia also suggests that these nuclear-stained cells
ere not infected primarily but were fused with neigh-
oring infected cells (fusion from within). Importantly,
nRNP-A1 colocalized with N protein in the perinuclear
egion of the infected cells (Fig. 8f), where MHV replica-
ion and transcription complex also localizes (Denison et
vernight (lanes 1 to 5). Then, the GST–N (full-length) protein immobi-
ized on the Sepharose beads (10 ml), which were saturated by the
ddition of an excessive amount of GST, was mixed with IVT-A1 and
ST–N(III) complex. Proteins not bound to the beads were washed
way and bound proteins were analyzed by electrophoresis on a 10%
olyacrylamide gel. Lane 6, 10% of the input volume of IVT-A1 products.
he arrow indicates the A1 protein. Molecular mass markers in kDa areFIG. 3. The interaction between N protein and hnRNP-A1 is specific.
he GST-binding assay (see Materials and Methods) was carried out to
etermine the interactions between GST–N and the in vitro translated
IVT) hnRNP-A1. (A) Lanes 1 and 2 indicate the interaction between
VT-A1 and GST–N following treatment of the lysates without (2) or with
1) micrococcal nuclease (mcn), respectively. Lane 3, GST plus IVT-A1
ithout micrococcal nuclease treatment; lane 4, 10% of the input vol-
me of the in vitro translation products used for the binding reaction.
he arrow indicates A1 protein. (B) Competition assay. Various
mounts (mg) of bovine serum albumin (BSA) as a nonspecific protein
ompetitor were added to the GST–N–Sepharose beads prior to the
ddition of IVT-A1 in a GST finding assay (lanes 2 to 6). Lane 1, 10% of
he input volume of IVT products. The arrow indicates A1 protein. (C)
ompetition assay with a specific competitor. Various amounts (0–40
g) of GST–N(III) fusion protein were added to a fixed amount of IVT-A1ndicated on the left.
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101INTERACTION BETWEEN MHV N AND hnRNP-A1l., 1999; Shi et al., 1999). These results suggest a pos-
ible link between hnRNP-A1 and N proteins and MHV
eplication/transcription apparatus.
nteractions between N protein and hnRNP-A1
n MHV-infected cells
The above finding on colocalization of hnRNP-A1 and
FIG. 4. Structural diagram of the N constructs and expression of GS
rotein and all primers used for PCR amplification and construction are
f Parker and Masters (1990). Below is the diagram of the full-length and
n the left, and their amino acid positions and lengths are shown on the
xpression of GST–N fusion proteins (lanes 1 to 17). Arrows indicate the
ndicated on the top and molecular mass markers in kDa on the left.proteins, however, did not indicate a physical interac- wion between them. To demonstrate a specific interaction
etween the two proteins in virus-infected cells, we em-
loyed an immunoaffinity method. If hnRNP-A1 interacts
ith the N protein, immunoprecipitation of the cytoplas-
ic extracts from MHV-infected cells by an antibody
pecific to one of the two proteins would bring down the
ther interacting partner. Two opposing approaches
sion proteins. (A) The three structural domains (I, II, and III) of the N
n at the top. The assignment of the domains is based on the proposal
s deletion N constructs. The names of individual constructs are shown
) Coomassie brilliant blue staining of a protein gel showing the correct
ponding protein species. Names of individual GST–fusion proteins areT–N fu
show
variou
right. (B
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102 WANG AND ZHANG-specific MAb to co-immunoprecipitate the N and any
ther possible interacting proteins in virus-infected cyto-
lasmic extracts. The immunocomplexes were sepa-
ated by SDS–polyacrylamide gel electrophoresis and
ere transferred to nitrocellulose membrane. The pres-
nce of hnRNP-A1 was then detected by Western blot
nalysis with a MAb specific to hnRNP-A1 and a goat
nti-mouse IgG antibody conjugated with peroxidase.
onsistent with the results from the fluorescence-stain-
ng experiment, co-immunoprecipitation of hnRNP-A1 by
he N antibody was detectable at 5 h p.i. and became
ore pronounced at 7 and 9 h p.i. (Fig. 9A), at which time
oints viral transcription also reaches a plateau. In the
econd experiment, we used the hnRNP-A1-specific
Ab for immunoprecipitation and the N-specific MAb for
estern blot analysis to detect whether N protein could
e coprecipitated by the hnRNP-A1-specific MAb. And
he results showed that this was indeed the case (Fig.
B). These data indicate that N protein interacted directly
ith hnRNP-A1 in MHV-infected cells.
However, it is also possible that RNAs present in the
nfected cell lysates might have mediated this interaction
FIG. 5. Dissection of the hnRNP-A1-interacting domains of MHV N
rotein. The interactions between GST–N fusion proteins and in vitro
ranslated hnRNP-A1 (IVT-A1) were determined in a GST-binding assay
see Materials and Methods). Proteins were analyzed by SDS–polyac-
ylamide gel (10%) electrophoresis. The gel was autoradiographed. The
ames of individual GST–N fusion proteins are indicated at the top of
he figure and corresponding lanes on the bottom (lanes 1 to 11). Lane
2 in (A) and lane 1 in (B) represent 10% of the input volume of the
VT-A1 products used for the interaction. The arrow denotes hnRNP-A1.
olecular mass markers in kDa are shown on the left.s discussed above for in vitro experiments. To investi- oate this possibility, cytoplasmic extracts were treated
ith micrococcal nuclease prior to immunoprecipitation.
his treatment effectively removed the exogeneously
dded mRNAs in a control experiment (data not shown)
ut did not significantly affect the amount of hnRNP-A1
recipitated by the anti-N antibody in Western blot com-
ared to that of the untreated extracts (Fig. 9C), indicat-
ng that viral and cellular mRNAs present in the lysates,
f any, did not have a bridging effect on this interaction.
nteractions between N protein and hnRNP-A1 in
east
Next, we employed the yeast two-hybrid system to
urther determine whether N protein interacts with
nRNP-A1 in vivo. The yeast two-hybrid system, devel-
ped by Fields and Song (1989), has been widely used
s a powerful tool to screen a library for a gene encoding
novel protein that interacts with a known target protein
r to test two known, previously cloned proteins for
nteraction in vivo. We cloned the full-length N gene and
nRNP-A1 gene fused either to the Gal4-DNA-binding
omain (DBD) or to the Gal4-transcriptional activation
omain (AD) of the vectors pAS2 (plasmid encoding the
BD) and pACT2 (plasmid encoding the AD), respec-
ively. We then co-transformed the pair of plasmid DNAs
pAS2-N and pACT2-A1, or pAS2-A1 and pACT2-N) into
he yeast strain Y187. Colonies grown on synthetic drop-
ut (SD) agar plates containing a selection medium [a
ynthetic minimal medium lacking tryptophan and
eucine (SD/-Trp/-Leu)] after incubation for 3 to 5 days at
FIG. 6. MHV N protein interacts with itself in vitro. The interaction
etween GST–N fusion proteins and in vitro translated N protein (IVT-N)
as determined in a GST binding assay (see Materials and Methods).
roteins were analyzed by SDS–polyacrylamide gel (10%) electrophoresis.
he gel was autoradiographed. The names of individual GST–N fusion
roteins are indicated at the top of the figure and corresponding lane
umbers at the bottom (lanes 2 to 6). Lane 7 shows the interactions
etween IVT-N and GST–A1 as a positive control. Lane 1 represents 10%
f the input volume of IVT-N products used for the reactions. Molecular
ass markers in kDa are shown on the left. Note that the relative intensityf the bands does not indicate their binding affinities in this figure.
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103INTERACTION BETWEEN MHV N AND hnRNP-A10°C were tested for the expression of b-galactosidase
ctivity by a colony-lift filter assay. As shown in Table 1,
o-transformation of pAS2-N and pACT2-A1 or of
AS2-A1 and pACT2-N resulted in the expression of
-galactosidase activity, indicating that the N protein
nteracted with hnRNP-A1 in yeast. In the control exper-
ments, the same yeast strain, which was co-transformed
ith two empty vectors, did not express b-galactosidase;
hen the yeast was co-transformed with pLAM59-1 and
TD1-1, which encodes an unrelated protein Gal4-DBD/
uman Lamin C hybrid and Gal4-AD/SV40 large T anti-
en, respectively, no b-galactosidase was detected.
east transformed with a single vector (either pAS2 or
ACT2) did not grow in the selection medium, indicating
hat there were no nonspecific interactions between pro-
eins expressed from the two vectors. Strong expression
f b-galactosidase was detected in the yeast co-trans-
ormed with pVA3-1 (plasmid encoding Gal4-DBD/murine
53) and pTD1-1, which serves as a positive control. The
east co-transformed with pAS2-A1 and pACT2-A1 grew
n the selection medium and expressed b-galactosidase
lightly more than that co-transformed with pAS2-A1 and
ACT2-N or with pAS2-N and pACT2-A1, but significantly
ower than the positive control (Table 1), indicating that
nRNP-A1 self-interaction appeared stronger than that
etween hnRNP-A1 and N protein. This result is also
onsistent with a previous report that showed that
nRNP-A1 self-interaction was approximately 30% of the
nteraction between p53 and SV40 large T antigen in the
FIG. 7. Summary of interactions between hnRNP-A1 and N proteins a
nly the N portions are shown and domains I–III are indicated. Inter
ranslated hnRNP-A1 (A1) or N (N) proteins are indicated on the right. 1
inding sites for A1 and N on the N protein are shown at the bottom.east two-hybrid system (Cartegni et al., 1996). tDISCUSSION
In the present study, we employed a series of bio-
hemical methods to test the hypothesis that MHV N
rotein interacts directly with a cellular protein
nRNP-A1, both of which have been implicated in the
egulation of MHV RNA replication and transcription
Compton et al., 1987; Stohlman et al., 1988; Zhang and
ai, 1995; Li et al., 1997). Our results clearly establish that
protein specifically interacts with hnRNP-A1 in vitro, in
irus-infected cells, and in yeast. To our knowledge, this
s the first report that coronavirus N protein has a pro-
ein-binding activity, binding to a cellular protein of the
utative transcription and replication complex, in addi-
ion to its known RNA-binding activity.
Our results showed that N and hnRNP-A1 proteins
olocalized in the cytoplasm of MHV-infected cells, thus
xtending our previous observation on intracellular re-
istribution of a single hnRNP-A1 protein (Li et al., 1997).
ignificantly, we found that the two proteins co-localized
redominantly in the perinuclear region of MHV-infected
ells (Fig. 8f), where active MHV replication/transcription
omplexes reside (Shi et al., 1999; Denison et al., 1999).
his suggests that both N and hnRNP-A1 proteins are
ossibly the components of the MHV replication/tran-
cription complex and that their interaction may be in-
olved in regulation of MHV RNA synthesis. The cyto-
lasmic redistribution of hnRNP-A1 in MHV-infected cells
bserved in this and a previous study (Li et al., 1997)
uggests a physical and, possibly, functional link be-
ween N and N proteins. Schematic diagram of GST–N fusion proteins:
between various GST–N fusion proteins and the full-length in vitro
ve interaction; 2, negative interaction; NT, not tested. The approximatend bet
actions
, positiween hnRNP-A1 and MHV infection. Alternatively, cyto-
p
d
b
e
r
r
n
o
m
r
t
c
c
c
t
v
d
t
s
t
p
t
a
i
t
q
t
t
h
a
t
S
t
w
o
w
t
m
s
t
p
m
p
i
m
t
b
i ation o
104 WANG AND ZHANGlasmic relocalization of hnRNP-A1 may be a passive
iffusion process due to leakage of the nuclear mem-
rane caused by MHV infection. This is less likely, how-
ver, because another nuclear protein, Sam68, which
elocalizes from the nucleus to the cytoplasm in poliovi-
us-infected cells (McBride et al., 1996), remains in the
ucleus of MHV-infected cells (Li et al., 1997). Also, the
bservation that hnRNP-A1 remained in the nuclei of
any MHV-infected cells, which exhibited positive fluo-
escence staining of N protein (data not shown), argues
hat MHV infection does not cause leakage of the nu-
lear membrane. In no instance we were able to detect
ytoplasmic localization of hnRNP-A1 in noninfected
ells even though hnRNP-A1 shuttles constantly be-
ween the nucleus and the cytoplasm.
The interaction between N and hnRNP-A1 might pro-
ide one of the mechanisms by which MHV regulates its
iscontinuous transcription. We previously proposed that
he interaction between the leader and the intergenic
equence of the template RNA, which is a critical step in
he initiation of mRNA transcription (based on the leader-
rimed transcription model), is mediated through pro-
FIG. 8. Co-localization of MHV N protein and cellular hnRNP-A1 in the
ultiplicity of infection of 1. At 0 (a–c) and 7 (d–f) hpi, cells were stained w
o N protein, followed by the rhodamine-conjugated anti-chicken IgG antibo
y laser confocal microscopy (Zeiss). (a and d) FITC-stained (green); (b an
ndicate the nuclear localization of hnRNP-A1 (red) but cytoplasmic localizein–RNA and protein–protein interactions, i.e., cellular tnd/or viral proteins first bind to the leader and the
ntergenic sequence of the template RNA through pro-
ein–RNA interactions; these two discontiguous RNA se-
uences are then brought together to form a transcrip-
ion initiation complex through protein–protein interac-
ions (Zhang and Lai, 1995). It has been shown that
nRNP-A1 binds to the intergenic sequence of the neg-
tive-strand template RNA (Zhang and Lai, 1995) and that
he N protein binds to the leader RNA (Baric et al., 1988;
tohlman et al., 1988). Thus, an attractive possibility is
hat the interaction between hnRNP-A1 and N proteins
ould bring the leader RNA to the intergenic sequence
f the template to form a ribonucleoprotein complex,
hich then regulates mRNA transcription. Alternatively,
he interaction between N and hnRNP-A1 might also
ediate discontinuous transcription during negative-
trand synthesis. In that case, N protein would bind to
he leader RNA of the genomic RNA template; hnRNP-A1
rotein would bind to the intergenic region of the nacent
inus-strand RNA transcript. hnRNP-A1 might be already
resent in the transcription complex or recruited to the
ntergenic site once the transcription complex moves
sm of MHV-infected cells. Cells were infected with MHV JHM strain at a
nRNP-A1-specific chicken antiserum and a monoclonal antibody specific
a FITC-conjugated anti-mouse IgG antibody. Stained cells were observed
odamine-stained (red); (c and f) merged image (orange). Arrows in d to f
f the N protein (green) in these cells within a syncytium.cytopla
ith an h
dy and
d e) rhoward the intergenic region. The presence of hnRNP-A1
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105INTERACTION BETWEEN MHV N AND hnRNP-A1t the intergenic site may facilitate an efficient termina-
ion (pause) of transcription and resume transcription at
he 39-end of the leader through interaction with N and
ther RNA-binding proteins that are bound to the tem-
late leader region. Regardless of which model may be
perative, our results are compatible with both models.
FIG. 9. Co-immunoprecipitation of hnRNP-A1 and N proteins from the
ytoplasmic extracts of MHV-infected cells by an antibody specific to N
r hnRNP-A1. (A) Cells were uninfected (2) (lane 1) or infected with
HV JHM strain at a multiplicity of infection of 1 (lanes 2 to 6). At 1, 3,
, 7, and 9 h postinfection (lanes 2 to 6), cytoplasmic lysates were
xtracted and immunoprecipitated with an N-specific monoclonal an-
ibody and protein A–agarose beads, and the immunocomplex was
eparated by electrophoresis on SDS–polyacrylamide gel (10%). Pro-
eins were transferred to a nitrocellulose membrane and visualized by
estern blot analysis using a monoclonal antibody specific to
nRNP-A1 and a peroxidase-conjugated secondary antibody against
ouse IgG. The arrow indicates hnRNP-A1 detected in the Western
lot. Molecular mass marker (M) in kilodalton (kDa) shown on the left.
B) Experiments were performed essentially the same as described in
A), except that a monoclonal antibody specific to hnRNP-A1 was used
or immunoprecipitation and an N-specific monoclonal antibody for
estern blot analysis. The arrow indicates the N protein detected in
estern blot. (C) Effects of micrococcal nuclease treatment. Experi-
ents were done in a manner similar to that for (A) lane 6, except that
he lysates were treated with (1) (lane 2) or without (2) (lane 1)
icrococcal nuclease (mcn) prior to immunoprecipitation.Recently, it has been shown that another cellular pro- tein, polypyrimidine tract-binding protein (PTB or hnRNP
), binds to the leader RNA (Li et al., 1999). Interaction
etween PTB and hnRNP-A1 has been documented
Dreyfuss et al., 1993). It is thus conceivable that PTB and
protein may have a synergistic function in bringing the
eader to the intergenic sequence for mRNA initiation
hrough interactions with hnRNP-A1 (leader-primed tran-
cription model) or in bringing the template leader to the
ntergenic site of minus-strand transcripts to resume
ranscription of the minus-strand subgenomic RNA (dis-
ontinuous transcription during minus-strand synthesis).
ased on the observation that antibodies specific to N
rotein inhibited MHV RNA replication in an in vitro
eplication system, Compton et al. (1987) suggested that
n interaction between the N protein and components of
he replicase/transcriptase complex might be required
or MHV RNA synthesis and that the binding of antibod-
es to N protein may inhibit such an interaction, thereby
nhibiting viral RNA synthesis. Our findings on the inter-
ction between N and hnRNP-A1 protein are consistent
ith this interpretation. It will be interesting to determine
hether N protein also interacts with PTB or other pro-
ein components of the replicase complex.
Our in vitro data also establish that the N protein
nteracts with itself (Fig. 6). Does the N protein also
nteract with itself in virus-infected cells or in virions? We
peculate that it probably does so. Robbins et al. (1986)
etected both monomeric and multimeric N proteins in
irions and infected cells. This suggests that N–N inter-
ctions may be important for encapsidation and virion
TABLE 1
Interaction between N and hnRNP-A1 in a Yeast
Two-Hybrid System
DBD vectorsa AD vectorsa Protein interactionb
pVA3-1 pTD1-1 1111
pAS2 — 2
— pACT2 2
pAS2 pACT2 2
pAS2-N pACT2-A1 1
pAS2-A1 pACT2-N 1
pAS2-A1 pACT2-A1 11
pLAM59-1 pTD1-1 2
a pAS2 and pACT2 are plasmid vectors encoding the Gal4 DNA-
inding domain and transcriptional activation domain, respectively.
AS2-N, pAS2-A1, pACT2-N, and pACT2-A1 are plasmids containing the
and hnRNP-A1 fused either to DBD or AD, respectively. pVA3-1 and
TD1-1 are DBD- and AD–fusion plasmids encoding murine p53 and
V40 large T antigen, respectively, that provide a positive control for
nteracting proteins. pLAM59-1 encodes a Gal4 DBD/human Lamin C
ybrid and provides a control for fortuitous interaction between an
nrelated DBD hybrid protein and an AD fusion protein.
b Protein interaction was determined by the colony-lift filter assay. 2,
hite or no colony, indicates no interaction; 1, blue colony, denotes a
ositive interaction. The larger the number of the plus signs, the darkerhe blue colony and the stronger the interaction.
a
p
d
H
i
i
p
t
m
s
(
i
a
t
m
m
d
T
d
r
t
V
u
t
v
m
M
c
p
S
e
o
u
t
w
P
P
c
c
w
N
(
t
u
p
m
m
N
c
T
a
p
t
(
w
p
e
E
a
r
t
2
a
v
p
e
t
eading
106 WANG AND ZHANGssembly. Identification of the interaction between N
roteins in this study thus provides biochemical evi-
ence in support of their finding (Robbins et al., 1986).
owever, an intriguing question raised from our results
s how the N–N protein interactions and the N-viral RNA
nteractions cooperate if the two different interaction
rocesses are important for encapsidation, since both
he protein-interacting (this study) and RNA-binding do-
ains (Masters, 1992; Nelson and Stohlman, 1993) re-
ide in a similar location of the N protein (domain IIA)
Figs. 5, 6, and 7). Does the protein–protein interaction
nterfere with the protein–RNA interaction during virus
ssembly or vice versa? An alternative explanation is
hat there are multiple protein-binding sites within do-
ains I and IIA of the N protein. This region (approxi-
ately 300 amino acids) is large enough to accommo-
ate both protein and RNA molecules at the same time.
his is possible since N–N interactions occur indepen-
ently in domains I and IIA (Fig. 6). Clearly, the biological
ole of the protein–protein interaction between N pro-
eins in virus assembly requires further investigation.
MATERIALS AND METHODS
irus, cells, and antibodies
The MHV JHM(2) strain (Makino and Lai, 1989) was
sed exclusively throughout this study. The murine as-
rocytoma cell line DBT (Hirano et al., 1974) was used for
irus growth, infection, and cell lysate preparation. The
ouse MAb J3.3.1 specific to the carboxy-terminal of the
HV N protein (Flemming et al., 1983) and the polyclonal
hicken antiserum against an Escherichia coli-ex-
ressed murine hnRNP-A1 were kindly provided by Drs.
tephen Stohlman and Michael Lai (University of South-
rn California, Los Angeles), respectively. The specificity
f the latter has been confirmed in Western blot analysis
sing murine hnRNP-A1 as antigens. A monoclonal an-
T
Oligonucleo
Primera Se
59BamN 59-TAG GGA TCC A
59BamN514 59-TAG GGA TCC G
59BamN653 59-TAG GGA TCC C
59BamN775 59-TAG GGA TCC G
59BamN904 59-TAG GGA TCC A
59BamN1199 59-TAG GGA TCC C
39EcoN183 59-TAG GAA TTC TG
39EcoN515 59-TAG GAA TTC G
39EcoN905 59-TAG GAA TTC G
39EcoN1199 59-TAG GAA TTC G
39EcoN 59-TAG GAA TTC TT
a All 59-primers are sense primers that contain a BamHI site, while
b Nucleotide position 30 is the first nucleotide of the N gene open ribody specific to the glycine-rich domain of hnRNP-A1 1as kindly provided by Dr. Gideon Dreyfuss (University of
ennsylvania).
lasmid constructions
To express the N protein and its deletion derivatives, a
DNA representing the N gene of MHV JHM strain was
loned into the vector pBluescript (Promega). Total RNAs
ere isolated from JHM virus-infected DBT cells by the
onidet-P-40 (NP-40) method as described previously
Zhang et al., 1994b). cDNAs were synthesized by reverse
ranscription using the primer 39EcoN and amplified by PCR
sing a primer pair 59BamN–39EcoN (Table 2). PCR was
erformed at 95°C for 30 s, 56°C for 1 min, and 72°C for 2
in in a reaction buffer (20 mM Tris, pH 8.3, 25 mM KCl, 1.5
M MgCl2, 0.1% Tween 20, a 200 mM concentration of each
TP, 20 pmol of each primer) for 25 cycles. The same PCR
onditions were used for all plasmid DNA constructions.
he PCR fragments were digested with BamHI and EcoRI
nd directionally cloned into pBluescript vector, generating
BS-N. Sequence of the clone was confirmed using a dye
erminator kit (ABI) with the automatic DNA sequencer
Prizm Model 377, ABI) (Skinner and Siddell, 1983). pBS-N
as then used for PCR amplication using various pairs of
rimers (see Table 2 and Fig. 4A). Because all sense prim-
rs contain a BamHI site and all antisense primers an
coRI site, the PCR fragments were digested with BamHI
nd EcoRI and were directionally cloned into pGEX4-1,
esulting in plasmids containing N and various domains of
he N protein fused to the carboxyl-terminus of GST (Table
and Fig. 6A). All deletion constructs contain a stop codon
t the 39-end to ensure that no additional sequence of the
ector would be expressed. For construction of pGST-NI-1,
GST-NI DNA was digested with DraI and EcoRI, blunt-
nded with T4 DNA polymerase, and self-ligated, such that
he smaller DraI–EcoRI fragment is deleted.
The previously constructed pBS-mA1 (Zhang et al.,
sed in PCR
Positions (nt)b
TTT GTT CCT-39 30–44
GTT GAA-39 514–527
G CCA A-39 653–666
G CCT AAG-39 775–788
AAT TTT G-39 904–918
CCT CAG A-39 1199–1212
GGC TGA-39 183–170
A GGT CCT AG-39 515–502
C TCT CTT TC-39 905–892
TAC ATC TG-39 1199–1186
ATT AGA GT-39 1397–1384
rimers are antisense primers that contain an EcoRI site.
frame.ABLE 2
tides U
quence
TG TCT
AT ATT
GT GG
GC CA
AT CAG
CT AAG
C TTG
GC AG
GG GC
CT CAC
A CAC
all 39-p999), which contains the full-length murine hnRNP-A1
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107INTERACTION BETWEEN MHV N AND hnRNP-A1equence under the control of T7 promoter in pBluescript
ector (Promega), was used for in vitro transcription and
ranslation (see below). pGST-mA1 (Li et al., 1997) was
sed for expressing hnRNP-A1 as a GST–fusion protein.
For control experiments, the previously constructed
25HE (Liao et al., 1995) and pDE-GFP (Zhang, unpub-
ished results) were used. p25HE and pDE-GFP are DI
ectors expressing MHV hemagglutinin/esterase and the
reen fluorescence protein, respectively. Both DIs were
igested with SnaBI and SpeI, blunt-ended with T4 DNA
olymerase, and separated by agarose gel electrophore-
is. The large fragments were self-ligated such that the
E or GFP ORF is under the control of T7 promoter.
For studying protein–protein interactions in the yeast
wo-hybrid system (Clontech), the Gal4-DNA-binding do-
ain vector pAS2 was digested with XmaI and blunt-
nded with T4 DNA polymerase. The N and hnRNP-A1
enes were isolated from the plasmids pBS-N and pGST-
A1, respectively, after digestion with BamHI and EcoRI,
lunt-ended with T4 DNA polymerase, and cloned into
he blunt-ended pAS2 vector, resulting in pAS2-N and
AS2-A1, respectively. The orientation of the inserts was
onfirmed by restriction enzyme digestions. For con-
truction of the Gal4–AD fusion vector, pACT2 was di-
ested with SfiI, blunt-ended with T4 DNA polymerase,
nd then digested with EcoRI. For preparing the N and
nRNP-A1 DNA fragments, pBS-N and pGST-mA1 were
igested with BamHI, blunt-ended, and then digested
ith EcoRI. The N and hnRNP-A1 genes were direction-
lly cloned into pACT2 vector, generating pACT2-N and
ACT2-A1, respectively.
n vitro transcription
For synthesis of RNAs used for in vitro translation,
BS-mA1 and pBS-N DNAs were linearized with EcoRI
nd subjected to in vitro transcription. The in vitro tran-
cription was carried out in a standard (50 ml) transcrip-
ion reaction containing 10 mM DTT, 1 U/ml RNasin, 0.5
M each of ATP, CTP, UTP, and cap analog, and 0.05 mM
TP, 5 mg pBS-mA1 or pBS-N, 40 U T7 RNA polymerase
t 37°C for 1 h according to the procedure recom-
ended by the manufacturer (Promega). To remove the
NA template following the transcription reaction, RQ
Nase (Promega) was added to a concentration of 1
nit/mg DNA and incubated at 37°C for 15 min. RNAs
ere purified by passing through a G25 or G50 column
59 Primer 39 Primer Inc.).
n vitro translation
The in vitro translation reaction was carried out in the
abbit reticulocyte lysate system in the presence of [35S]me-
hionine using the in vitro transcribed RNAs according to
he manufacturer’s recommendations (Promega). For some
xperiments, the lysate was treated with micrococcal nu-
lease (20 units/ml) in the presence of 1 mM calcium thloride at 20°C for 10 min following the in vitro translation.
he micrococcal nuclease was then inactivated by adding
thylene glycol-bis[b-aminoethyl ether]-N,N,N9,N9-tetraace-
ic acid at a final concentration of 2 mM.
xpression of GST–fusion proteins
The procedure for expressing GST–fusion proteins
as based on the protocols as described (Smith and
ohnson, 1988; Ausubel et al., 1989). Briefly, pGST-mA1
nd pGST-N and its deletion derivatives were trans-
ormed into E. coli (DH5a), and the transformants were
rown at 37°C overnight in LB medium in the presence
f ampicillin (100 mg/ml). Bacterial cultures were diluted
ith fresh LB medium and incubated for 4 h. At 2 h
ollowing the addition of isopropyl-thio-b-D-galactopyr-
noside, bacterial cultures were collected by centrifuga-
ion, resuspended in phosphate-buffered saline (PBS),
nd lysed by ultrasonication. Soluble proteins were pu-
ified with glutathione–Sepharose beads (Pharmacia).
ound proteins were then eluted by adding free gluta-
hione at 10 mM in Tris buffer (pH 8.0).
rotein-binding assay
GST-binding assays were performed as previously de-
cribed (Ausubel et al., 1989). Briefly, 20 ml (approximate-
y 10 mg) of GST–fusion proteins, coupled to Sepharose
eads as described above, was mixed with 5 ml of in vitro
ranslated 35S-labeled A1 protein in 400 ml of binding
uffer [40 mM (HEPES), pH 7.9, 100 mM KCl, 0.1% NP-40,
0 mM b-mercaptoethanol]. After a 4-h incubation at 4°C
n a rotating platform, beads were pelleted by centrifu-
ation at 1000 g in microcentrifuge tubes. The beads
ere then washed four times with 1 ml of the binding
uffer. After the final wash, the bead pellets were resus-
ended in 20 ml of 13 Lammeli’s sample buffer, boiled
or 3 min, and recentrifuged, and the supernatants were
nalyzed by SDS–PAGE.
mmunofluorescence assay
DBT cells were grown on 8-well chamber slides (Lab
ak, Nunc, Nalgene) to subconfluency and infected with
HM virus at an m.o.i. of 1. At different times p.i., cells
ere fixed with 2% formaldehyde in PBS for 30 min at
oom temperature and permeabilized with acetone for 10
in at 220°C. Fixed cells were incubated at 37°C for 1 h
n a humidified box following the addition of a mixture of
wo antibodies (mouse MAb J3.3.1 to N protein and a
hicken antiserum to hnRNP-A1). After extensive wash-
ng with PBS, cells were stained simultaneously with two
econdary antibodies [a rabbit anti-mouse IgG(H1L)-
ntibody conjugated with FITC (Sigma) and a goat anti-
hicken IgG(H1L) antibody conjugated with rhodamine
Sigma)] for 1 h at 37°C. Slides were then washed with
BS and mounted with coverslips. Intracellular localiza-ion of hnRNP-A1 and the N protein was observed under
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108 WANG AND ZHANGhe fluorescence microscope (Olympic 1000) with a
avelength of 254 nm for fluorescein and 355 nm for
hodamine. Photographs were taken using the confocal
aser scanning microscope at the Core Facility of the
rkansas Cancer Research Center.
xtraction of cytoplasmic proteins
Extraction of cytoplasmic proteins was carried out as
escribed previously (Zhang et al., 1994b). Briefly, DBT
ells were grown on 100-mm petri dishes to confluency
nd mock-infected or infected with JHM virus at an m.o.i.
f 5. At various time points p.i., culture medium was
emoved. Cells were washed with ice-cold PBS twice,
craped with a rubber policeman into microcentrifuge
ubes, and pelleted by centrifugation for 20 s. Cell pellets
ere resuspended in 300 ml of an extraction buffer [10
M HEPES, pH 7.9, 10 mM KCl, 0.1 mM ethylenediami-
etetraacetic acid, 1 mM dithiothreitol (DTT), 0.5 mM
henylmethylsulfonyl fluoride (PMSF)] by gentle pipetting
nd incubated on ice for 15 min. Following the addition of
5 ml of 10% NP-40, the cell suspension was mixed
igorously by vortexing for 20 s and centrifuged at 4°C
or 2 min in a microcentrifuge. Pellets, which contain the
uclei, were discarded, and supernatants, which repre-
ent the cytoplasmic fraction, were collected. The protein
oncentration of the cytoplasmic extracts was deter-
ined with a Bio-Rad protein assay kit (Bio-Rad).
mmunoprecipitation
Immunoprecipitation was carried out in 500 ml of RIPA
uffer (50 mM Tris, pH 7.4, 150 mM NaCl, 0.5% NP-40,
.1% SDS, 1 mM PMSF) containing various amounts of
nfected and noninfected cytoplasmic extracts and the
-specific MAb J3.3.1 by constant rocking on a rocking
latform at 4°C overnight. The antibody–antigen com-
lexes were then precipitated with protein A–agarose
eads at 4°C for 2–4 h. Agarose beads were washed
hree times with RIPA buffer. Proteins complexes were
enatured by boiling for 3 min in Lammeli’s sample
oading buffer (100 mM Tris, pH 6.8, 200 mM DTT, 4%
DS, 0.2% bromophenol blue, 20% glycerol) and analyzed
y PAGE. Proteins were then detected by Western blot
nalysis. For detection of in vitro protein–protein interac-
ions, the GST–fusion proteins and the in vitro-translated
roteins were mixed in RIPA buffer followed by the ad-
ition of N-specific MAb J3.3.1. Immunoprecipitates were
nalyzed by SDS–PAGE and the gels were exposed to
-ray film and autoradiographed.
estern blot
Western blot was performed as described previously
Zhang et al., 1994a) with slight modifications. Briefly,
ollowing SDS–PAGE, proteins were transferred onto ni-
rocellulose membranes (Amersham) using a Bio-Radini Transfer Blot at 60 V overnight at 4°C. Membranes Dere dried and blocked with either 10% skim milk or 2%
ovine serum albumin in PBS for 2 h at 37°C. The
embranes were incubated with the primary antibody
MAb specific to hnRNP-A1, 1:500 dilution) for 2 h at
7°C. After extensive washing, the membranes were
ncubated with a goat anti-mouse IgG secondary anti-
ody conjugated with horseradish peroxidase (1:10,000
ilution) (Sigma) for 2 h. The substrate, diaminobenzidine
0.075%), and hydrogen peroxide (0.003%) were used to
isualize the protein bands.
he yeast two-hybrid system
The Matchmaker Two-Hybrid System 2 (Clontech, Palo
lto, CA) was used for testing the interaction between
he N protein and hnRNP-A1 in vivo. All procedures for
rowing yeast, transformation, selection, and b-galacto-
idase colony-lift filter assay essentially followed the
rotocol provided by the manufacturer (Clontech).
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